1. Home
  2. CPOP vs TLPH Comparison

CPOP vs TLPH Comparison

Compare CPOP & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pop Culture Group Co. Ltd

CPOP

Pop Culture Group Co. Ltd

HOLD

Current Price

$0.32

Market Cap

36.4M

ML Signal

HOLD

TLPH

Talphera Inc.

HOLD

Current Price

$0.88

Market Cap

37.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPOP
TLPH
Founded
2007
2005
Country
China
United States
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.4M
37.9M
IPO Year
2020
2010

Fundamental Metrics

Financial Performance
Metric
CPOP
TLPH
Price
$0.32
$0.88
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
84.1K
227.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,151,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.30
$0.38
52 Week High
$2.60
$1.57

Technical Indicators

Market Signals
Indicator
CPOP
TLPH
Relative Strength Index (RSI) 37.38 48.37
Support Level $0.30 $0.86
Resistance Level $0.48 $1.05
Average True Range (ATR) 0.02 0.06
MACD 0.00 0.02
Stochastic Oscillator 30.19 54.83

Price Performance

Historical Comparison
CPOP
TLPH

About CPOP Pop Culture Group Co. Ltd

Pop Culture Group Co Ltd hosts entertainment events, operates hip-hop-related online programs, and provides event planning and execution services and marketing services to corporate clients. It generates revenue from Event Hosting business by providing sponsorship packages to advertisers in exchange for sponsorship fees and by selling tickets for those concerts. The company has various operations services out of which Brand Promotion earns maximum revenue, following by Event Hosting, and Event Planning and Execution.

About TLPH Talphera Inc.

Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.

Share on Social Networks: